Also, lower dose EPO or derivatives of EPO, such as darbepoetin, are routinely used to prevent anemia of prematurity in infants and have been reported to have benefit in some clinical studies.37 Therefore, studying EPO or derivatives and their signaling effects on features involved in ROP pathophysiology is highly important and clinically relevant.33 This evidence concerns the gene EPO and anemia.